Selected research
Industry Research
In - Vitro ADME Services Industry Research Report 2026
Market perspective
The global In - Vitro ADME Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the In - Vitro ADME Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the In - Vitro ADME Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the In - Vitro ADME Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of In - Vitro ADME Services include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec and IQVIA, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global In - Vitro ADME Services market in terms of revenue (US$ million) and, where applicable, service volume (Tons), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to In - Vitro ADME Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In - Vitro ADME Services Market by Company
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
In - Vitro ADME Services Segment by Type
Small Molecules
Biologics
In - Vitro ADME Services Segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
In - Vitro ADME Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In - Vitro ADME Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In - Vitro ADME Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In - Vitro ADME Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In - Vitro ADME Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Molecules
- Biologics
Applications
- Biopharmaceutical Companies
- Government and Academic Institutes
- Others
Companies covered
- Charles River
- Labcorp
- Envigo
- Curia
- Evotec
- Bioduro-Sundia
- Lonza
- WuXi AppTec
- IQVIA
- Tecan Group
- Pharmaron
- Shanghai Medicilon
- ChemPartner
- Joinn Laboratories
- RTI International
- Eurofins Scientific
- Aragen Life Sciences
- Sai Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 In - Vitro ADME Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Small Molecules
- 2.2.3 Biologics
- 2.3 In - Vitro ADME Services by End User
- 2.3.1 Market Value Comparison by End User (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Companies
- 2.3.3 Government and Academic Institutes
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 In - Vitro ADME Services Breakdown Data by Type
- 3.1 Global In - Vitro ADME Services Historic Market Size by Type (2021-2026)
- 3.2 Global In - Vitro ADME Services Forecasted Market Size by Type (2027-2032)
4 In - Vitro ADME Services Breakdown Data by End User
- 4.1 Global In - Vitro ADME Services Historic Market Size by End User (2021-2026)
- 4.2 Global In - Vitro ADME Services Forecasted Market Size by End User (2027-2032)
5 Global Growth Trends
- 5.1 Global In - Vitro ADME Services Market Perspective (2021-2032)
- 5.2 Global In - Vitro ADME Services Growth Trends by Region
- 5.2.1 Global In - Vitro ADME Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 In - Vitro ADME Services Historic Market Size by Region (2021-2026)
- 5.2.3 In - Vitro ADME Services Forecasted Market Size by Region (2027-2032)
- 5.3 In - Vitro ADME Services Market Dynamics
- 5.3.1 In - Vitro ADME Services Industry Trends
- 5.3.2 In - Vitro ADME Services Market Drivers
- 5.3.3 In - Vitro ADME Services Market Challenges
- 5.3.4 In - Vitro ADME Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top In - Vitro ADME Services Players by Revenue
- 6.1.1 Global Top In - Vitro ADME Services Players by Revenue (2021-2026)
- 6.1.2 Global In - Vitro ADME Services Revenue Market Share by Players (2021-2026)
- 6.2 Global In - Vitro ADME Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of In - Vitro ADME Services Head Office and Area Served
- 6.4 Global In - Vitro ADME Services Players, Product Type & Application
- 6.5 Global In - Vitro ADME Services Manufacturers Established Date
- 6.6 Global In - Vitro ADME Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America In - Vitro ADME Services Market Size (2021-2032)
- 7.2 North America In - Vitro ADME Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America In - Vitro ADME Services Market Size by Country (2021-2026)
- 7.4 North America In - Vitro ADME Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe In - Vitro ADME Services Market Size (2021-2032)
- 8.2 Europe In - Vitro ADME Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe In - Vitro ADME Services Market Size by Country (2021-2026)
- 8.4 Europe In - Vitro ADME Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific In - Vitro ADME Services Market Size (2021-2032)
- 9.2 Asia-Pacific In - Vitro ADME Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific In - Vitro ADME Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific In - Vitro ADME Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America In - Vitro ADME Services Market Size (2021-2032)
- 10.2 South America In - Vitro ADME Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America In - Vitro ADME Services Market Size by Country (2021-2026)
- 10.4 South America In - Vitro ADME Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa In - Vitro ADME Services Market Size (2021-2032)
- 11.2 Middle East & Africa In - Vitro ADME Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa In - Vitro ADME Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa In - Vitro ADME Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River
- 12.1.1 Charles River Company Information
- 12.1.2 Charles River Business Overview
- 12.1.3 Charles River Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.1.4 Charles River In - Vitro ADME Services Product Portfolio
- 12.1.5 Charles River Recent Developments
- 12.2 Labcorp
- 12.2.1 Labcorp Company Information
- 12.2.2 Labcorp Business Overview
- 12.2.3 Labcorp Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.2.4 Labcorp In - Vitro ADME Services Product Portfolio
- 12.2.5 Labcorp Recent Developments
- 12.3 Envigo
- 12.3.1 Envigo Company Information
- 12.3.2 Envigo Business Overview
- 12.3.3 Envigo Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.3.4 Envigo In - Vitro ADME Services Product Portfolio
- 12.3.5 Envigo Recent Developments
- 12.4 Curia
- 12.4.1 Curia Company Information
- 12.4.2 Curia Business Overview
- 12.4.3 Curia Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.4.4 Curia In - Vitro ADME Services Product Portfolio
- 12.4.5 Curia Recent Developments
- 12.5 Evotec
- 12.5.1 Evotec Company Information
- 12.5.2 Evotec Business Overview
- 12.5.3 Evotec Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.5.4 Evotec In - Vitro ADME Services Product Portfolio
- 12.5.5 Evotec Recent Developments
- 12.6 Bioduro-Sundia
- 12.6.1 Bioduro-Sundia Company Information
- 12.6.2 Bioduro-Sundia Business Overview
- 12.6.3 Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.6.4 Bioduro-Sundia In - Vitro ADME Services Product Portfolio
- 12.6.5 Bioduro-Sundia Recent Developments
- 12.7 Lonza
- 12.7.1 Lonza Company Information
- 12.7.2 Lonza Business Overview
- 12.7.3 Lonza Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.7.4 Lonza In - Vitro ADME Services Product Portfolio
- 12.7.5 Lonza Recent Developments
- 12.8 WuXi AppTec
- 12.8.1 WuXi AppTec Company Information
- 12.8.2 WuXi AppTec Business Overview
- 12.8.3 WuXi AppTec Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.8.4 WuXi AppTec In - Vitro ADME Services Product Portfolio
- 12.8.5 WuXi AppTec Recent Developments
- 12.9 IQVIA
- 12.9.1 IQVIA Company Information
- 12.9.2 IQVIA Business Overview
- 12.9.3 IQVIA Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.9.4 IQVIA In - Vitro ADME Services Product Portfolio
- 12.9.5 IQVIA Recent Developments
- 12.10 Tecan Group
- 12.10.1 Tecan Group Company Information
- 12.10.2 Tecan Group Business Overview
- 12.10.3 Tecan Group Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.10.4 Tecan Group In - Vitro ADME Services Product Portfolio
- 12.10.5 Tecan Group Recent Developments
- 12.11 Pharmaron
- 12.11.1 Pharmaron Company Information
- 12.11.2 Pharmaron Business Overview
- 12.11.3 Pharmaron Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.11.4 Pharmaron In - Vitro ADME Services Product Portfolio
- 12.11.5 Pharmaron Recent Developments
- 12.12 Shanghai Medicilon
- 12.12.1 Shanghai Medicilon Company Information
- 12.12.2 Shanghai Medicilon Business Overview
- 12.12.3 Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.12.4 Shanghai Medicilon In - Vitro ADME Services Product Portfolio
- 12.12.5 Shanghai Medicilon Recent Developments
- 12.13 ChemPartner
- 12.13.1 ChemPartner Company Information
- 12.13.2 ChemPartner Business Overview
- 12.13.3 ChemPartner Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.13.4 ChemPartner In - Vitro ADME Services Product Portfolio
- 12.13.5 ChemPartner Recent Developments
- 12.14 Joinn Laboratories
- 12.14.1 Joinn Laboratories Company Information
- 12.14.2 Joinn Laboratories Business Overview
- 12.14.3 Joinn Laboratories Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.14.4 Joinn Laboratories In - Vitro ADME Services Product Portfolio
- 12.14.5 Joinn Laboratories Recent Developments
- 12.15 RTI International
- 12.15.1 RTI International Company Information
- 12.15.2 RTI International Business Overview
- 12.15.3 RTI International Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.15.4 RTI International In - Vitro ADME Services Product Portfolio
- 12.15.5 RTI International Recent Developments
- 12.16 Eurofins Scientific
- 12.16.1 Eurofins Scientific Company Information
- 12.16.2 Eurofins Scientific Business Overview
- 12.16.3 Eurofins Scientific Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.16.4 Eurofins Scientific In - Vitro ADME Services Product Portfolio
- 12.16.5 Eurofins Scientific Recent Developments
- 12.17 Aragen Life Sciences
- 12.17.1 Aragen Life Sciences Company Information
- 12.17.2 Aragen Life Sciences Business Overview
- 12.17.3 Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.17.4 Aragen Life Sciences In - Vitro ADME Services Product Portfolio
- 12.17.5 Aragen Life Sciences Recent Developments
- 12.18 Sai Life Sciences
- 12.18.1 Sai Life Sciences Company Information
- 12.18.2 Sai Life Sciences Business Overview
- 12.18.3 Sai Life Sciences Revenue in In - Vitro ADME Services Business (2021-2026)
- 12.18.4 Sai Life Sciences In - Vitro ADME Services Product Portfolio
- 12.18.5 Sai Life Sciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst